Smith & Nephew SNATS Basic Shares Outstanding 2010-2024 | SNN

Smith & Nephew SNATS annual/quarterly basic shares outstanding history and growth rate from 2010 to 2024. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
  • Smith & Nephew SNATS basic shares outstanding for the quarter ending December 31, 2024 were $0M, a 0% increase year-over-year.
  • Smith & Nephew SNATS basic shares outstanding for the twelve months ending December 31, 2024 were $0M, a 0% increase year-over-year.
  • Smith & Nephew SNATS annual basic shares outstanding for 2024 were $0.437B, a 0.23% increase from 2023.
  • Smith & Nephew SNATS annual basic shares outstanding for 2023 were $0.436B, a 0.11% decline from 2022.
  • Smith & Nephew SNATS annual basic shares outstanding for 2022 were $0.436B, a 0.57% decline from 2021.
Smith & Nephew SNATS Annual Basic Shares Outstanding
(Millions of US $)
2024 $437
2023 $436
2022 $436
2021 $439
2020 $438
2019 $437
2018 $437
2017 $437
2016 $445
2015 $447
2014 $447
2013 $451
2012 $448
2011 $446
2010 $444
2009 $442
Smith & Nephew SNATS Quarterly Basic Shares Outstanding
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2015-12-31
2015-06-30
2014-12-31 $449
2014-09-30 $447
2014-06-30 $447
2014-03-31 $446
2013-12-31 $448
2013-09-30 $452
2013-06-30 $451
2013-03-31 $453
2012-12-31 $449
2012-09-30 $447
2012-06-30 $446
2012-03-31 $447
2011-12-31 $446
2011-09-30 $443
2011-06-30 $445
2011-03-31 $446
2010-12-31 $444
2010-09-30 $457
2010-06-30 $445
2010-03-31 $442
2009-12-31 $441
2009-09-30 $441
2009-06-30 $442
2009-03-31 $445
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $12.666B $5.810B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.294B 27.81
Boston Scientific (BSX) United States $157.073B 39.32
Stryker (SYK) United States $146.485B 30.63
EssilorLuxottica (ESLOY) France $131.510B 0.00
Medtronic (MDT) Ireland $104.117B 14.76
Haleon (HLN) United Kingdom $50.587B 28.80
Lonza Group Ag (LZAGY) Switzerland $49.544B 0.00
ResMed (RMD) United States $36.103B 27.12
GE HealthCare Technologies (GEHC) United States $32.514B 15.44
Agilent Technologies (A) United States $31.721B 20.95
Terumo (TRUMY) Japan $28.131B 36.54
Insulet (PODD) United States $22.987B 90.23
Koninklijke Philips (PHG) Netherlands $21.694B 15.60
Zimmer Biomet Holdings (ZBH) United States $18.639B 11.97
Baxter (BAX) United States $15.842B 11.83
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.269B 21.81
Lantheus Holdings (LNTH) United States $5.242B 13.22
Prestige Consumer Healthcare (PBH) United States $4.244B 18.96
Perrigo (PRGO) Ireland $3.757B 9.52
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.266B 14.88
ICU Medical (ICUI) United States $3.210B 23.67
Envista Holdings (NVST) United States $3.051B 25.35
GN Store Nord (GNNDY) Denmark $2.163B 17.92
QuidelOrtho (QDEL) United States $2.114B 14.54
LeMaitre Vascular (LMAT) United States $1.868B 41.76
AtriCure (ATRC) United States $1.683B 0.00
Neogen (NEOG) United States $1.335B 17.08
Acuren (TIC) United States $1.317B 0.00
AdaptHealth (AHCO) United States $1.256B 12.75
Kestra Medical Technologies (KMTS) United States $1.156B 0.00
Green Thumb Industries (GTBIF) United States $1.120B 25.19
BioLife Solutions (BLFS) United States $1.057B 0.00
Phibro Animal Health (PAHC) United States $0.991B 12.67
InMode (INMD) Israel $0.919B 9.26
Evolus (EOLS) United States $0.633B 0.00
CeriBell (CBLL) United States $0.625B 0.00
Curaleaf Holdings (CURLF) Canada $0.590B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.568B 0.00
Valneva SE (VALN) France $0.534B 0.00
Owens & Minor (OMI) United States $0.509B 4.22
Capricor Therapeutics (CAPR) United States $0.479B 0.00
Tilray Brands (TLRY) Canada $0.446B 0.00
Surmodics (SRDX) United States $0.412B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.339B 0.00
Cresco Labs (CRLBF) United States $0.324B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.86
Canopy Growth (CGC) Canada $0.313B 0.00
Aurora Cannabis (ACB) Canada $0.307B 54.70
Sanara MedTech (SMTI) United States $0.274B 0.00
Viemed Healthcare (VMD) United States $0.261B 22.00
ZimVie (ZIMV) United States $0.245B 11.11
Cerus (CERS) United States $0.241B 0.00
Sanuwave Health (SNWV) United States $0.239B 0.00
Verano Holdings (VRNOF) United States $0.237B 0.00
Biote (BTMD) United States $0.223B 6.28
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
OraSure Technologies (OSUR) United States $0.207B 0.00
Brainsway (BWAY) Israel $0.201B 53.25
Quanterix (QTRX) United States $0.197B 0.00
Omeros (OMER) United States $0.186B 0.00
High Tide (HITI) Canada $0.185B 0.00
Organigram Global (OGI) Canada $0.179B 0.00
Utah Medical Products (UTMD) United States $0.178B 14.46
Exagen (XGN) United States $0.145B 0.00
FitLife Brands (FTLF) United States $0.136B 16.69
Jin Medical (ZJYL) China $0.124B 0.00
TerrAscend (TSNDF) Canada $0.114B 0.00
MacroGenics (MGNX) United States $0.094B 0.00
Agape ATP (ATPC) $0.092B 0.00
Fonar (FONR) United States $0.089B 11.42
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Zynex (ZYXI) United States $0.078B 0.00
Quipt Home Medical (QIPT) United States $0.076B 0.00
Veru (VERU) United States $0.075B 0.00
InterCure (INCR) Israel $0.071B 0.00
Apyx Medical (APYX) United States $0.067B 0.00
Jushi Holdings (JUSHF) United States $0.060B 0.00
ImmuCell (ICCC) United States $0.056B 0.00
United Health Products (UEEC) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
Modular Medical (MODD) United States $0.047B 0.00
United-Guardian (UG) United States $0.039B 13.47
Rockwell Medical (RMTI) United States $0.033B 0.00
Nephros (NEPH) United States $0.031B 41.86
Safety Shot (SHOT) United States $0.029B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00